COLANGIOSCOPIA PER LE STENOSI BILIARI IN CORSO DI COLANGITE PRIMARIA SCLEROSANTE. L’USO DEL “COLOR ENHANCEMENT IMAGING”. UN MAGNIFICO VIDEO DA” AMERICAN JOURNAL OF GASTROENTEROLOGY”

ENDOSCOPIA, EPATOLOGIA, EPATOLOGIA ONCOLOGICA, NEWSLETTER, Senza categoria

Cholangioscopy for Primary Sclerosing Cholangitis With Biliary Strictures Using Texture and Color Enhancement Imaging and Red Dichromatic Imaging. Tomohiro Ishi et al   LEGGI TUTTO https://pubmed.ncbi.nlm.nih.gov/39887125/#:~:text=doi%3A%2010.14309/ajg.0000000000002878.            

URCA! L’EFFETTO DELLA TERAPIA NEI TRIAL E’ DOVUTO SOPRATTUTTO AL PLACEBO! TUTTI A CASA! OPPURE LEGGIAMO E STUDIAMO QUESTA META-REGRESSIONE! DA “JOURNAL OF CLINICAL EPIDEMIOLOGY” (FREE)

GASTROENTEROLOGIA, METODOLOGIA, NEWSLETTER, Senza categoria

Treatment effects in pharmacological clinical randomized controlled trials are mainly due to placebo Stefan Schmidt et al. Highlights •Meta-regressions were used to assess placebo-effects in pharmacological randomized controlled trials. •The analyses accounted for natural history and regression to the mean. °∼72% of treatment outcomes could be explained by other factors than treatment itself. •Pharmacological effects explain…

IBD! SCREENING E VACCINAZIONI PER I PAZIENTI CON MALATTIE INFIAMMATORIE DELL’INTESTINO: EXPERT REVIEW DA “Clinical Gastroenterology and Hepatology” (FREE)

GASTROENTEROLOGIA, IBD, NEWSLETTER, ONCOLOGIA, Senza categoria

Non-colorectal Cancer Screening and Vaccinations in Patients with Inflammatory Bowel Disease: Expert Review Freddy Caldera et al Description The aim of this American Gastroenterological Association (AGA) Clinical Practice Update (CPU) is to provide best practice advice (BPA) statements for gastroenterologists and other health care providers who provide care to patients with inflammatory bowel disease (IBD). The…

BREAKING NEWS! IL PRIMO ANALGESICO NON-OPPIOIDE APPROVATO DALLA FOOD & DRUG AGENCY. E’ POTENTE. DA “NATURE” (FREE)

EPATOLOGIA ONCOLOGICA, GASTROENTEROLOGIA, INTERNATIONAL SNAPSHOTS, MEDICI DI FAMIGLIA, MEDICINA INTERNA, NEWSLETTER, ONCOLOGIA, Senza categoria

US drug agency approves potent painkiller — the first non-opioid in decades The FDA’s nod for suzetrigine bolsters confidence in the pharmaceutical industry’s strategy to target sodium channels Elie Dolgin Researchers have long sought potent, but non-addictive, painkillers as alternatives to opioids.Credit: Getty When Terp Vairin awoke from a 2023 surgery that straightened a bend…

EFFICACIA E RISCHI DEGLI AGONISTI AI RECETTORI GLP-1. IL PIU’ GRANDE STUDIO RETROSPETTIVO AD OGGI (SOPRA 1,5 MILIONI PAZ) . LEGGETELO! DA”NATURE MEDICINE”

EPATOLOGIA, GASTROENTEROLOGIA, MEDICI DI FAMIGLIA, MEDICINA INTERNA, NEWSLETTER, NUTRIZIONE, ONCOLOGIA, Senza categoria

Mapping the effectiveness and risks of GLP-1 receptor agonists Yan Xie et al. Glucagon-like peptide 1 receptor agonists (GLP-1RAs) are increasingly being used to treat diabetes and obesity. However, their effectiveness and risks have not yet been systematically evaluated in a comprehensive set of possible health outcomes. Here, we used the US Department of Veterans…